Genetic Testing for P Ca â€“ What the Urologists Should Know
Personalized (Precision) Medicine is assuming
Importance for the management of many cancers and Prostate cancer is no exception.
For this Genetic Testing is becoming important. In P Ca, this is assuming
importance in not only for the treatment of Advanced P Ca (metastatic) but also
finding relevance in planning Active Surveillance, even for Very Low Risk P Caâ€™s.
I am providing an excerpt from the Panel
Discussion at AUA Conference 2020. The panellists, comprising of Leonard
Gomella as the lead with Todd Morgan and Veda Giri as panellists. They have
outlined the importance of what the Urologists should know concerning Genetic
Testing and how it can shape the treatment options more effectively
I am also providing the link for â€˜Implementation Germline Testing
for P Ca Philadelphia P Ca Consensus Conference 2019â€™ by Veda N. Giri, Michael S Cookson, Leonard G Gomella et al (2020, JCO) for those
who are interested in more detailed knowledge.
With warm Regards,